409 related articles for article (PubMed ID: 30823365)
1. Autophagy in Zika Virus Infection: A Possible Therapeutic Target to Counteract Viral Replication.
Gratton R; Agrelli A; Tricarico PM; Brandão L; Crovella S
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823365
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Target of Rapamycin Signaling Activation Antagonizes Autophagy To Facilitate Zika Virus Replication.
Sahoo BR; Pattnaik A; Annamalai AS; Franco R; Pattnaik AK
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878890
[TBL] [Abstract][Full Text] [Related]
3. Zika Virus Induces Autophagy in Human Umbilical Vein Endothelial Cells.
Peng H; Liu B; Yves TD; He Y; Wang S; Tang H; Ren H; Zhao P; Qi Z; Qin Z
Viruses; 2018 May; 10(5):. PubMed ID: 29762492
[TBL] [Abstract][Full Text] [Related]
4. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
Kim JA; Seong RK; Kumar M; Shin OS
Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176
[TBL] [Abstract][Full Text] [Related]
5. Nuclear import inhibitor N-(4-hydroxyphenyl) retinamide targets Zika virus (ZIKV) nonstructural protein 5 to inhibit ZIKV infection.
Wang C; Yang SNY; Smith K; Forwood JK; Jans DA
Biochem Biophys Res Commun; 2017 Dec; 493(4):1555-1559. PubMed ID: 28988109
[TBL] [Abstract][Full Text] [Related]
6. Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.
Pires de Mello CP; Tao X; Kim TH; Vicchiarelli M; Bulitta JB; Kaushik A; Brown AN
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967017
[TBL] [Abstract][Full Text] [Related]
7. Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication.
Monel B; Rajah MM; Hafirassou ML; Sid Ahmed S; Burlaud-Gaillard J; Zhu PP; Nevers Q; Buchrieser J; Porrot F; Meunier C; Amraoui S; Chazal M; Salles A; Jouvenet N; Roingeard P; Blackstone C; Amara A; Schwartz O
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534046
[TBL] [Abstract][Full Text] [Related]
8. Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy.
Liang Q; Luo Z; Zeng J; Chen W; Foo SS; Lee SA; Ge J; Wang S; Goldman SA; Zlokovic BV; Zhao Z; Jung JU
Cell Stem Cell; 2016 Nov; 19(5):663-671. PubMed ID: 27524440
[TBL] [Abstract][Full Text] [Related]
9. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
Kamiyama N; Soma R; Hidano S; Watanabe K; Umekita H; Fukuda C; Noguchi K; Gendo Y; Ozaki T; Sonoda A; Sachi N; Runtuwene LR; Miura Y; Matsubara E; Tajima S; Takasaki T; Eshita Y; Kobayashi T
Antiviral Res; 2017 Oct; 146():1-11. PubMed ID: 28818572
[TBL] [Abstract][Full Text] [Related]
10. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus.
Pitts JD; Li PC; de Wispelaere M; Yang PL
Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080
[TBL] [Abstract][Full Text] [Related]
13. ZIKA virus entry mechanisms in human cells.
Agrelli A; de Moura RR; Crovella S; Brandão LAC
Infect Genet Evol; 2019 Apr; 69():22-29. PubMed ID: 30658214
[TBL] [Abstract][Full Text] [Related]
14. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
Pires de Mello CP; Tao X; Kim TH; Bulitta JB; Rodriquez JL; Pomeroy JJ; Brown AN
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109164
[TBL] [Abstract][Full Text] [Related]
15. Role of autophagy in Zika virus infection and pathogenesis.
Chiramel AI; Best SM
Virus Res; 2018 Aug; 254():34-40. PubMed ID: 28899653
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol affects Zika virus replication in vitro.
Mohd A; Zainal N; Tan KK; AbuBakar S
Sci Rep; 2019 Oct; 9(1):14336. PubMed ID: 31586088
[TBL] [Abstract][Full Text] [Related]
17. Zika Virus Replicons for Drug Discovery.
Xie X; Zou J; Shan C; Yang Y; Kum DB; Dallmeier K; Neyts J; Shi PY
EBioMedicine; 2016 Oct; 12():156-160. PubMed ID: 27658737
[TBL] [Abstract][Full Text] [Related]
18. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
[TBL] [Abstract][Full Text] [Related]
19. Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator.
Wang X; Xia S; Zou P; Lu L
Viruses; 2019 Nov; 11(11):. PubMed ID: 31731598
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine and Sulfadoxine Derivatives Inhibit ZIKV Replication in Cervical Cells.
de Souza AAA; Torres LR; Capobianco LRPL; de Paula VS; Cascabulho CM; Salomão K; Bonecini-Almeida MDG; Ferreira MLG; Boechat N; Pinheiro LCDS; de Souza EM
Viruses; 2020 Dec; 13(1):. PubMed ID: 33383619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
